
Amgen Inc
AMGNHealthcare|Drug Manufacturers - General|USA
$342.57
-5.37 (-1.54%)
DCF (FCF)
$219.78
Earnings Power
$83.10
Analyst Ratings
| Firm / Analyst | Rating | Price Target | Date |
|---|---|---|---|
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — |
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812"
],
"revenue_estimate": [
37823,
38764.52,
39736.13
],
"ebit_estimate": [
16689.41,
16958.65,
17317.37
],
"ebitda_estimate": [
20964.87,
21198.2,
20890.49
],
"net_income_estimate": [
12106.36,
12555.66,
13032.08
],
"per_share_eps_estimate": [
15.29,
16.38,
17.4
],
"eps_nri_estimate": [
22.39,
23.31,
24.45
],
"dividend_estimate": [
10.24,
10.89,
11.34
],
"book_value_per_share_estimate": [
17.69,
30.84,
39.83
],
"pretax_income_estimate": [
14479.11,
15042.26,
15531.73
],
"operating_cash_flow_per_share_estimate": [
26.06,
28.93,
29.48
],
"roa_estimate": [
10.57,
11.67,
12.27
],
"roe_estimate": [
104.29,
84.68,
71.72
],
"gross_margin_estimate": [
81.5,
81.61,
82.35
],
"operating_cash_flow_estimate": [
14123,
15678.43,
15980.49
],
"pettm_estimate": [
22.41,
20.92,
19.69
],
"long_term_growth_rate_mean": 3.86,
"long_term_revenue_growth_rate_mean": "2.62",
"future_per_share_eps_estimate_growth": 6.95,
"future_eps_nri_estimate_growth": 3.86,
"future_revenue_estimate_growth": 2.62,
"future_ebit_estimate_growth": 12.57,
"future_ebitda_estimate_growth": 6.69,
"future_dividend_estimate_growth": 6.05,
"future_net_income_estimate_growth": 17.48,
"future_pretax_income_estimate_growth": 18.33,
"future_book_value_per_share_estimate_growth": 38.8,
"future_roa_estimate_growth": 12.94,
"future_roe_estimate_growth": -12.92,
"future_gross_margin_estimate_growth": 6.28,
"future_operating_cash_flow_per_share_estimate_growth": 16.46
}
quarterly
{
"date": [
"202603",
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
8594.79,
9458.57,
9679.38,
10016.36,
8976.95,
9632.83,
9834,
10221.15
],
"ebit_estimate": [
3653.79,
4271.32,
4319.35,
4355.49,
3941.9,
4220.3,
4270.77,
4354.67
],
"ebitda_estimate": [
4763.36,
5728.8,
6365.67,
7053.76,
null,
null,
null,
null
],
"net_income_estimate": [
2594.4,
3094.86,
3120.51,
3152.78,
2846.07,
3066.77,
3107.23,
3167.8
],
"per_share_eps_estimate": [
3.34,
3.91,
4.46,
4.08,
4.13,
4.34,
4.28,
4.12
],
"eps_nri_estimate": [
4.73,
5.77,
5.79,
5.99,
5.14,
5.69,
5.75,
6.02
],
"dividend_estimate": [
2.59,
2.59,
2.59,
2.59,
2.84,
2.84,
2.84,
2.84
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
3055.05,
3680.8,
3762.24,
3850.06,
3259.35,
3761.45,
3913.65,
4247
],
"operating_cash_flow_per_share_estimate": [
5.09,
5.95,
5.97,
5.9,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
80.62,
80.96,
81.03,
80.91,
78.5,
78.75,
78.85,
78.95
],
"operating_cash_flow_estimate": [
2758.78,
3224.9,
3235.74,
3197.8,
null,
null,
null,
null
],
"pettm_estimate": [
21.69,
20.66,
20.15,
20.37,
20.32,
null,
null,
null
],
"long_term_growth_rate_mean": 3.86,
"long_term_revenue_growth_rate_mean": "2.62",
"future_per_share_eps_estimate_growth": 6.95,
"future_eps_nri_estimate_growth": 3.86,
"future_revenue_estimate_growth": 2.62,
"future_ebit_estimate_growth": 12.57,
"future_ebitda_estimate_growth": 6.69,
"future_dividend_estimate_growth": 6.05,
"future_net_income_estimate_growth": 17.48,
"future_pretax_income_estimate_growth": 18.33,
"future_book_value_per_share_estimate_growth": 38.8,
"future_roa_estimate_growth": 12.94,
"future_roe_estimate_growth": -12.92,
"future_gross_margin_estimate_growth": 6.28,
"future_operating_cash_flow_per_share_estimate_growth": 16.46
}